Orchid Pharma Fair Value
Orchid Pharma (ORCHPHARMA) average fair value is ₹281.74 across 4 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹761.35 (-63.0%), fair value range ₹40.57–₹664.56. Examine ORCHPHARMA quarterly performance for recent quarterly revenue, profit and EPS trends.
Fair Value Analysis Export
ORCHPHARMA Fair Value vs Current Price — Valuation Summary
ORCHPHARMA average fair value, fair value range, price gap and valuation status across 4 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). See ORCHPHARMA price book multiple to compare market price against book value per share.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
ORCHPHARMA Fair Value Analysis — Data Sources & Coverage
Orchid Pharma financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. For live price and a broader fundamental view, visit Orchid Pharma share price chart.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
ORCHPHARMA vs Healthcare Sector Peers — P/E, P/B & Market Cap
Orchid Pharma P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Accretion Pharmaceuticals | ACCPL | 13.72 | 2.43 | ₹131 |
| Par Drugs & Chemical | PAR | 8.67 | 1.01 | ₹111 |
| Jeena Sikho Lifecare | JSLL | 40.02 | 22.33 | ₹7,891 |
| Auro Laboratories | AUROLAB | 91.49 | 3.91 | ₹165 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.